- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 144,307,555
- Total 13F shares
- 122,578,572
- Share change
- +3,493,818
- Total reported value
- $9,264,040,265
- Put/Call ratio
- 41%
- Price per share
- $75.51
- Number of holders
- 264
- Value change
- +$268,135,107
- Number of buys
- 151
- Number of sells
- 100
Quarterly Holders Quick Answers
What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - VAXCYTE INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92243G108:
Top shareholders of PCVX - VAXCYTE INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
16,261,159
|
$1,110,799,797 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.7%
|
9,737,254
|
$665,151,821 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.6%
|
9,513,007
|
$649,833,509 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.7%
|
8,203,754
|
$560,398,436 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
5.3%
|
7,673,868
|
$524,117,484 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.4%
|
4,919,370
|
$336,042,164 | — | 31 Mar 2024 | |
| Capital Research Global Investors |
13F
|
Company |
2.9%
|
4,140,521
|
$282,838,990 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.5%
|
3,552,967
|
$242,704,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
3,337,092
|
$227,956,755 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.2%
|
3,176,181
|
$216,966,000 | — | 31 Mar 2024 | |
| Darwin Global Management, Ltd. |
13F
|
Company |
1.9%
|
2,750,804
|
$187,907,421 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
2,287,375
|
$156,272,989 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.5%
|
2,147,656
|
$146,706,371 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.3%
|
1,932,759
|
$132,026,767 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,867,807
|
$127,589,896 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.2%
|
1,780,703
|
$121,639,822 | — | 31 Mar 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.1%
|
1,586,095
|
$108,346,149 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
1,396,711
|
$95,409,328 | — | 31 Mar 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.87%
|
1,256,883
|
$85,857,681 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.86%
|
1,239,995
|
$84,704,058 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.86%
|
1,234,509
|
$84,329,310 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.84%
|
1,212,703
|
$82,839,742 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.81%
|
1,161,777
|
$79,360,987 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.79%
|
1,139,405
|
$77,832,756 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.74%
|
1,066,131
|
$72,827,409 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.72%
|
1,046,032
|
$71,454,446 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.67%
|
968,757
|
$66,175,790 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.6%
|
861,569
|
$58,853,978 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.6%
|
860,000
|
$58,746,600 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
13F
|
Company |
0.59%
|
845,000
|
$57,721,950 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.58%
|
833,618
|
$56,944,446 | — | 31 Mar 2024 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.55%
|
793,036
|
$54,172,494 | — | 31 Mar 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.52%
|
745,000
|
$50,890,950 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.48%
|
698,492
|
$47,713,988 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.47%
|
685,000
|
$46,792,350 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
657,206
|
$44,893,742 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.4%
|
575,000
|
$39,278,250 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.34%
|
490,454
|
$33,502,922 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.33%
|
475,700
|
$32,495,067 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.32%
|
461,724
|
$31,540,382 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.3%
|
425,750
|
$29,082,983 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
412,525
|
$28,179,584 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.27%
|
393,704
|
$26,893,920 | — | 31 Mar 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.27%
|
384,363
|
$26,256,000 | — | 31 Mar 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.26%
|
377,400
|
$25,780,194 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.25%
|
367,249
|
$25,086,779 | — | 31 Mar 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.25%
|
355,131
|
$24,258,999 | — | 31 Mar 2024 | |
| Jeff Fairman |
3/4/5
|
VP, Research |
—
mixed-class rows
|
369,054
mixed-class rows
|
$22,935,618 | — | 30 Dec 2022 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.23%
|
338,800
|
$22,608,124 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
311,352
|
$21,268,455 | — | 31 Mar 2024 |
Institutional Holders of VAXCYTE INC - COMMON STOCK (PCVX) as of Q2 2024
As of 30 Jun 2024,
VAXCYTE INC - COMMON STOCK (PCVX) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,578,572 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, T. Rowe Price Investment Management, Inc., STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
265
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
249
Q2 2024 holders
264
Holder diff
15
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.